MedTrace Logo

The Effect of Deep Oscillation and Myofascial Relaxation With Chronic Nonspecific Low Back Pain

NCT04759404 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2022-08-11

No results posted yet for this study

Summary

In our study, it was aimed to investigate the effects of deep oscillation and myofascial release on pain, functionality and quality of life in individuals with chronic nonspecific low back pain. 72 individuals who voluntarily agree to participate in the study will be included. Participants will be randomly divided into three groups, the deep oscillation group, myofascial release and the control group. Home exercises including stretching and strengthening for waist, back and abdominals will be given to all groups. However, in addition to the deep oscillation group, deep oscillation will be applied to the lumbar region and myofascial relaxation will be applied to the lumbar region for the myofascial group. Individuals will be asked to come to the center where the research will be conducted for a total of six sessions for two weeks, three times a week. Participants' pain will be evaluated with Visual Analog Scale, disability status with Oswestry Disability Index, sleep quality with Pittsburgh Sleep Quality Index, and quality of life with Short Form-36 before and after the first treatment in the first treatment. Statistical analysis to be used in our research will be done with the Statistical Package for the Social Sciences 20.0 package program.

Conditions

  • Low Back Pain

Interventions

OTHER

Deep Oscillation Treatment

Deep oscillation to the lumbar region and stretching and strengthening exercise for waist, back and abdominal

OTHER

Myofascial Release Treatment

Myofascial release to the lumbar region and stretching and strengthening exercise for waist, back and abdominal

Sponsors & Collaborators

  • Bahçeşehir University

    lead OTHER

Principal Investigators

  • Leyla Ataş Balcı, Assist Prof · Bahçeşehir University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-15
Primary Completion
2021-03-08
Completion
2021-05-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04759404 on ClinicalTrials.gov